Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of QuadraMune(TM) for Prevention of COVID-19 in High Risk Populations

NCT04421391 is registered in ClinicalTrials.gov with Therapeutic Solutions International as lead sponsor.

NCT NCT04421391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04421391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of QuadraMune(TM) for Prevention of COVID-19 in High Risk Populations
Lead sponsor
Therapeutic Solutions International
Phase
Not applicable
Overall status
Unknown status
Start date
June 8, 2020
Completion date
November 8, 2020
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid19, sars-cov 2